Discover 722 paid clinical trials in Overland Park, Kansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 722
Active & Responsive
Efficacy of Point Of Service Testing in MBC
for
Metastatic Cancer, Breast Cancer
Location: Kansas City KS
Sponsor: University of Kansas Medical Center
Sex: All
Age: 18+
Code: NCT03983577
Recruiting
Active & Responsive
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
for
Advanced Melanoma
Location: Westwood KS, St Louis MO, Oklahoma City OK,
Sponsor: Immunocore Ltd
Sex: All
Age: 18+
Code: NCT05549297
Phase3, Recruiting
Active & Responsive
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
for
Chronic Migraine
Location: Overland Park KS, Omaha NE, City of Saint Peters MO,
Sponsor: Merz Therapeutics GmbH
Sex: All
Age: 18+
Code: NCT07018713
Phase3, Recruiting
Active & Responsive
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
for
Episodic Migraine
Location: Overland Park KS, Omaha NE, City of Saint Peters MO,
Sponsor: Merz Therapeutics GmbH
Sex: All
Age: 18+
Code: NCT07018700
Phase3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
for
NASH - Nonalcoholic Steatohepatitis,
Location: Kansas City MO, Topeka KS, Columbia MO, St Louis MO,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06528314
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
for
NASH With Fibrosis, MASH With Fibrosis
Location: Kansas City MO, Topeka KS, Columbia MO, St Louis MO,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06215716
Phase3, Recruiting
Active & Responsive
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
for
Obesity, Overweight
Location: Kansas City MO, Newton KS, Norman OK, Skokie IL,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07684235
Phase3, Recruiting
Active & Responsive
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Location: Kansas City MO, Topeka KS, Lincoln NE, Papillion NE,
Sponsor: Amgen
Sex: All
Age: 45 - 70+
Code: NCT07037433
Phase3, Recruiting
Active & Responsive
A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.
for
Spasticity
Location: Overland Park KS, Dallas TX, Elkins Park PA, Downey CA
Sponsor: Ipsen
Sex: All
Age: 18 - 70
Code: NCT04752774
Phase1, Phase2, Recruiting
Active & Responsive
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
for
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Location: Overland Park KS, Columbia MO, McKinney TX, Chicago IL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 12+
Code: NCT06338995
Phase3, Recruiting
Active & Responsive
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
for
Treatment Resistant Depression
Location: Kansas City KS, Columbia MO, Lincoln NE, Tulsa OK,
Sponsor: LivaNova
Sex: All
Age: 18+
Code: NCT03887715
Recruiting
Active & Responsive
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
for
Breast Atypical Hyperplasia, Breast Carcinoma,
Location: Kansas City KS, Ann Arbor MI, Columbus OH
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 45 - 70+
Code: NCT06195306
Phase2, Recruiting
Active & Responsive
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors, Genital Neoplasm, Female,
Location: Kansas City KS, Madison WI, Nashville TN, Columbus OH,
Sponsor: Marengo Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05592626
Phase1, Phase2, Recruiting
Active & Responsive
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
for
Breast Atypical Hyperplasia, Breast Carcinoma,
Location: Kansas City KS, Chicago IL, Columbus OH, Duarte CA
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 35+
Code: NCT05941520
Phase2, Recruiting
Active & Responsive
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
for
Lymphoma, Non-Hodgkin, B-cell Lymphoma,
Location: Kansas City KS, Iowa City IA, Rochester MN, Chicago IL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07101328
Phase1, Recruiting
Active & Responsive
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)